Federal IDR outcomes: General and other surgery in Maryland
In 2025 Q1–Q4, the provider or facility offer prevailed in 78.2% of 655 determined Federal IDR dispute line items for general and other surgery in Maryland. The median prevailing offer was 8.27x the QPA (25th–75th percentile 2.57x–16.45x; n = 474). The median time to a decision was 31 business days (n = 655).
Determined line items
655
2025 Q1–Q4 · 1 split decisions excluded
Provider win rate
78.2%
n = 655 · 2025 Q1–Q4
Median payment vs QPA
8.27x
middle half 2.57x–16.45x · n = 474 · 2025 Q1–Q4
Median days to decision
31
business days, from dispute initiation · n = 655 · 2025 Q1–Q4
Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.
By period
| Period | Line items | Win % | Median ×QPA | 25th–75th | Ratio n | Median days |
|---|---|---|---|---|---|---|
| 2025 Q1–Q4 | 655 | 78.2% | 8.27x | 2.57x–16.45x | 474 | 31 |
| 2024 Q1–Q4 | 276 | 90.6% | 9.69x | 7.02x–17.15x | 183 | 32 |
| 2023 Q1–Q4 | Fewer than 30 determined line items; not shown. | |||||
| 2023 Q1–2025 Q4 | 931 | 81.8% | 8.64x | 4.88x–16.53x | 657 | not pooled |
Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.
Most disputed CPT codes
| CPT code | Line items | Win % | Median ×QPA | Ratio n | Median days |
|---|---|---|---|---|---|
| 58662 Destruction or removal of ovary or growth of pelvis using an endoscope | 105 | 71.4% | 8.18x | 80 | 26 |
| 49203 Removal or destruction of cysts or growths of abdominal cavity, 5.0 cm or less | 68 | 82.4% | 9.22x | 65 | 54 |
| 50715 Release of scar tissue at ureter | 63 | 77.8% | 7.64x | 56 | 40 |
| 52260 Dilation of bladder using an endoscope under general or spinal anesthesia | 62 | 80.6% | – | 18 | 32 |
| 58146 Removal of 5 or more growths of uterus through abdomen | 57 | 77.2% | 14.41x | 53 | 28 |
| 58558 Biopsy of lining of uterus and/or removal of polyp using an endoscope | 47 | 72.3% | – | 22 | 21 |
| 58544 Partial removal of uterus, tubes, and/or ovaries with retention of cervix using | 36 | 91.7% | – | 29 | 28 |
2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.
Related: all specialties in Maryland · General and other surgery in all states
FAQ
What is the Federal IDR provider win rate for general and other surgery in Maryland?
In 2025 Q1–Q4, the provider or facility offer was selected in 78.2% of 655 determined dispute line items for general and other surgery in Maryland. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.
How do Federal IDR payments compare with the QPA for general and other surgery in Maryland?
In 2025 Q1–Q4, the median prevailing offer was 8.27x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 2.57x to 16.45x (n = 474 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.
How long do Federal IDR decisions take for general and other surgery in Maryland?
In 2025 Q1–Q4, the median was 31 business days (n = 655 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).